| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Zoghbi Huda Y | Director | 777 OLD SAW MILL RIVER ROAD, TARRYTOWN | /s/ Huda Y. Zoghbi | 23 Feb 2026 | 0001681643 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | REGN | Common Stock | Options Exercise | $617,018 | +1,638 | +96% | $376.69 | 3,341 | 19 Feb 2026 | Direct | F1 |
| transaction | REGN | Common Stock | Sale | $37,959 | -49 | -1.5% | $774.68 | 3,292 | 19 Feb 2026 | Direct | F1 |
| transaction | REGN | Common Stock | Sale | $38,775 | -50 | -1.5% | $775.50 | 3,242 | 19 Feb 2026 | Direct | F1 |
| transaction | REGN | Common Stock | Sale | $41,259 | -53 | -1.6% | $778.47 | 3,189 | 19 Feb 2026 | Direct | F1, F2 |
| transaction | REGN | Common Stock | Sale | $162,146 | -208 | -6.5% | $779.55 | 2,981 | 19 Feb 2026 | Direct | F1, F3 |
| transaction | REGN | Common Stock | Sale | $258,329 | -331 | -11% | $780.45 | 2,650 | 19 Feb 2026 | Direct | F1, F4 |
| transaction | REGN | Common Stock | Sale | $163,288 | -209 | -7.9% | $781.28 | 2,441 | 19 Feb 2026 | Direct | F1, F5 |
| transaction | REGN | Common Stock | Sale | $233,066 | -298 | -12% | $782.10 | 2,143 | 19 Feb 2026 | Direct | F1, F6 |
| transaction | REGN | Common Stock | Sale | $172,324 | -220 | -10% | $783.29 | 1,923 | 19 Feb 2026 | Direct | F1, F7 |
| transaction | REGN | Common Stock | Sale | $125,512 | -160 | -8.3% | $784.45 | 1,763 | 19 Feb 2026 | Direct | F1, F8 |
| transaction | REGN | Common Stock | Sale | $43,994 | -56 | -3.2% | $785.61 | 1,707 | 19 Feb 2026 | Direct | F1, F9 |
| transaction | REGN | Common Stock | Sale | $3,160 | -4 | -0.23% | $790.00 | 1,703 | 19 Feb 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | REGN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1,638 | -67% | $0.000000 | 800 | 19 Feb 2026 | Common Stock | 1,638 | $376.69 | Direct | F1, F10 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. |
| F2 | Represents volume-weighted average price of sales of 53 shares of Company stock on February 19, 2026 at prices ranging from $778.46 to $778.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
| F3 | Represents volume-weighted average price of sales of 208 shares of Company stock on February 19, 2026 at prices ranging from $779.10 to $779.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
| F4 | Represents volume-weighted average price of sales of 331 shares of Company stock on February 19, 2026 at prices ranging from $780.06 to $780.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
| F5 | Represents volume-weighted average price of sales of 209 shares of Company stock on February 19, 2026 at prices ranging from $781.10 to $781.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
| F6 | Represents volume-weighted average price of sales of 298 shares of Company stock on February 19, 2026 at prices ranging from $782.01 to $782.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
| F7 | Represents volume-weighted average price of sales of 220 shares of Company stock on February 19, 2026 at prices ranging from $783.00 to $783.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
| F8 | Represents volume-weighted average price of sales of 160 shares of Company stock on February 19, 2026 at prices ranging from $784.14 to $784.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
| F9 | Represents volume-weighted average price of sales of 56 shares of Company stock on February 19, 2026 at prices ranging from $785.60 to $785.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
| F10 | The stock option vested in three equal annual installments, commencing one year after the date of grant. |